 | Up a level |
Chapman, Judith-Anne W; Bayani, Jane; SenGupta, Sandip; Bartlett, John M S; Piper, Tammy; Quintayo, Mary Anne; Virk, Shakeel; Goss, Paul E; Ingle, James N; Ellis, Matthew J; Sledge, George W; Budd, G Thomas; Rabaglio, Manuela; Ansari, Rafat H; Tozer, Richard; D'Souza, David P; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A; ... (2024). Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole. Journal of clinical oncology, 42(24), pp. 2887-2898. American Society of Clinical Oncology 10.1200/JCO.24.00835
Goss, Paul E.; Ingle, James N.; Pritchard, Kathleen I.; Ellis, Matthew J.; Sledge, George W.; Budd, G. Thomas; Rabaglio, Manuela; Ansari, Rafat H.; Johnson, David B.; Tozer, Richard; D'Souza, David P.; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A.; Liedke, Pedro E. R.; Lang, Istvan; Elliott, Catherine; Gelmon, Karen A.; Chapman, Judy-Anne W.; ... (2013). Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial. Journal of clinical oncology, 31(11), pp. 1398-1404. American Society of Clinical Oncology 10.1200/JCO.2012.44.7805
